PXD058653 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Integrated proteomic, DNA methylation, and targeted Next Generation Sequencing reveals relevant heterogeneity in lower-grade meningioma and a new target in NF2 mutated meningiomas |
Description | Meningiomas, the most common primary brain tumours, are classified by the World Health Organization (WHO) into grades 1, 2, and 3. Some grade 1 tumours exhibit increased clinical aggressiveness with the biallelic mutation of Neurofibromatosis 2 (NF2) being the most frequent mutation reported. In our study, we analysed the most common driver mutations (NF2, AKT1, KLF4, and TRAF7) in meningioma by proteomics and genomics focussing on lower grade tumours. Our genomic data revealed co-occurrences of non-NF2 mutations in lower-grade meningiomas suggesting synergistic effects supporting tumour growth. NF2-/- meningiomas showed distinct proteomic clustering, with different mutations found in these clusters. Additionally, proteomics identified ANXA3 in NF2-/- meningioma and its role in proliferation was confirmed in grade1 and subsequently grade 3 tumours in vitro and with abolished growth when tested in meningioma mouse model. These findings highlight new targets in different meningioma backgrounds presenting ANXA3 as a potential therapeutic target for meningioma treatment. |
HostingRepository | PRIDE |
AnnounceDate | 2025-07-02 |
AnnouncementXML | Submission_2025-07-02_03:18:32.462.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Vikram Sharma |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | No PTMs are included in the dataset |
Instrument | Orbitrap Fusion Lumos |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2024-12-06 08:24:47 | ID requested | |
⏵ 1 | 2025-07-02 03:18:33 | announced | |
Publication List
10.1016/j.ebiom.2025.105814; |
Shah M, Akther Y, Adams CL, Banton MC, Sharma V, Ercolano E, Hilton DA, Kurian KM, Laraba L, Woznica W, Parkinson DB, de Assis LJ, Hanemann CO, Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas. EBioMedicine, ():105814(2025) [pubmed] |
Keyword List
submitter keyword: Genomics, NF2, Proteomics,Meningioma |
Contact List
Vikram Sharma |
contact affiliation | School of Biomedical Sciences, University of Plymouth, UK |
contact email | vikram.sharma@plymouth.ac.uk |
lab head | |
Vikram Sharma |
contact affiliation | Plymouth University Peninsula Schools of Medicine and Dentistry |
contact email | vikram.sharma@plymouth.ac.uk |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/07/PXD058653 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD058653
- Label: PRIDE project
- Name: Integrated proteomic, DNA methylation, and targeted Next Generation Sequencing reveals relevant heterogeneity in lower-grade meningioma and a new target in NF2 mutated meningiomas